The most important financial indicators for the company Neuroptics Med Srl - Unique Identification Number 29179363:
sales in 2023 was
235.981
euro, registering a net profit of
5.025
euro and having an average number of
4
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al altor bunuri noi, in magazine specializate having the NACE code 4778.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 8.3%, from 218.560 euro in the year 2022, to 235.981 euro in 2023.
The Net Profit increased by 5.025 euro, from 0 euro in 2022, to 5.025 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Neuroptics Med Srl - CUI 29179363
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
62.427
79.513
101.631
140.215
113.263
132.909
104.839
146.750
128.521
94.495
Current Assets
35.602
58.536
56.137
68.528
68.666
69.989
56.080
40.442
50.988
56.087
Inventories
20.435
21.435
26.854
30.576
32.413
35.004
28.946
20.995
27.966
22.834
Receivables
13.826
16.012
20.227
26.351
23.000
25.286
18.832
16.683
13.390
15.292
Cash
1.341
21.089
9.056
11.601
13.253
9.698
8.303
2.764
9.632
17.962
Shareholders Funds
23.087
57.764
61.992
92.825
133.768
133.761
121.379
126.710
-13.436
-8.370
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
75.664
81.014
96.460
116.500
49.108
70.165
40.555
61.561
193.838
158.951
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4778 - 4778"
CAEN Financial Year
4778
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
56.087 euro in 2023 which includes Inventories of
22.834 euro, Receivables of
15.292 euro and cash availability of
17.962 euro.
The company's Equity was valued at
-8.370 euro, while total Liabilities amounted to
158.951 euro.
Equity increased by 5.025 euro, from -13.436 euro in 2022, to -8.370 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Neuroptics Med Srl